Acute Lung Injury Overview

Principles

Definition

Acute lung injury is a critical concept in biomedical research concerning rapid-onset, diffuse inflammatory damage to the lung parenchyma. This research field investigates the underlying pathological mechanisms, diverse etiologies (such as sepsis, pneumonia, and trauma), diagnostic criteria, and therapeutic strategies associated with this severe form of acute respiratory failure. Key characteristics of research in this area include interdisciplinary study of complex inflammatory pathways, cellular injury, and physiological dysfunction, holding significant importance due to the substantial morbidity and mortality rates linked to the syndrome.

Ontological type

Pathophysiology

Therapeutic Strategies

Etiology and Risk Factors

Key developments

Key Figures

Physiology and Mechanical Support era

In this physiologic–mechanical era, Ashbaugh, Bigelow, Petty, and Levine's 1967 report on acute respiratory distress in adults defined ARDS as diffuse alveolar damage with edema driving hypoxemia. John B. West contributed diffusion–reaction models of alveolar–capillary gas transfer and edema physiology that clarified how barrier disruption impairs oxygenation. Clinicians and researchers such as Robert Bartlett demonstrated extracorporeal membrane oxygenation for severe respiratory failure in ARDS, while ventilatory management ideas—PEEP optimization and prone positioning—began translating physiology into bedside strategies. Together these lines advanced a unified framework linking gas-exchange physics, barrier integrity, and mechanical support to preserve oxygen transport and limit ventilator-induced injury.

Alveolar Barrier Protection era

Arthur S. Slutsky [1] is a leading figure in Alveolar Barrier Protection during the 1990–2009 era, with affiliations at Harvard University [3] and The University of Texas Health Science Center at San Antonio [4]. His key contributions include the 1994 paper Tidal ventilation at low airway pressures can augment lung injury [8] and the 2005 paper Angiotensin-converting enzyme 2 protects from severe acute lung failure [7], which together advanced understanding of how ventilation strategies and innate protective pathways shape alveolar barrier integrity in this era. Stefan Uhlig [2] is a pivotal contributor in this era, with affiliations spanning Erasmus University Rotterdam [5] and the University of Toronto [6]. His listed paper Angiotensin-converting enzyme 2 protects from severe acute lung failure [7] underscores the importance of ACE2-mediated protection for alveolar barrier function and innate immune modulation across institutions.

Phenotype-Guided Molecular Targeting era

Mohammad Naimul Islam [1] is associated with Columbia University [3] and the University of Florida [4] in this era. His work on mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury, as reported in the 2012 paper [6], illustrating a cell-based mechanism with potential to modulate redox and immune pathways in this era. Jahar Bhattacharya [2] is affiliated with Columbia University [3] and Columbia College [5] in this era. His contributions, as reflected in the same 2012 paper [6], highlight mitochondrial transfer as a transformative mechanism for protecting lung tissue in acute injury and for guiding biomarker‑driven, targeted redox strategies characteristic of precision phenotyping.